Award
Delivery Order #SPE2D326F6312
Short-Term Delivery Order for ADACEL TDAP Vaccine by DMS Pharmaceutical
Buyer
Defense Logistics Agency
Award Amount
$309.99
Ceiling
$309.99
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2D326F6312
NAICS
325411
This award is a delivery order under an existing long-term indefinite delivery, indefinite quantity (IDIQ) contract with DMS Pharmaceutical Group Inc., a specialized pharmaceutical manufacturer and distributor. The contract procures a specific vaccine product, the ADACEL TDAP 0.5ML vial, used for immunization against tetanus, diphtheria, and pertussis. This procurement supports public health initiatives by ensuring the availability of critical vaccines for government healthcare programs. The scope involves delivering the specified vaccine within a short, defined period of a few days, highlighting an urgent or routine replenishment of vaccine stocks. The delivery order is linked to a sizeable foundational contract established to provide injectable pharmaceuticals flexibly over a multi-year timeline. Although competitive or sole-source details are not specified for this particular order, it operates under the terms of the overarching IDIQ agreement that facilitates adaptable procurement. The place of performance is in Park Ridge, Illinois, and the contract's brief duration indicates a focused supply task within a larger framework of pharmaceutical support.
Description
4570898317!ADACEL TDAP VIAL 0.5ML